IMNN today
$0.64-$0.08 (-11.57%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourSymmetric Triangle
1 hourLeaning Bearish
15 minStrong Bearish
5 minStrong Bearish
Daily trend turns up above $1.59
Key levels
Resistance$1.27
Resistance$0.96
Latest news & SEC filings
EarningsImunon holds Q3 2026 earnings call
SEC FilingImunon, Inc. filed a report on a major company event (Form 8-K)
EarningsImunon posts wider quarterly loss than analysts expected
All IMNN news →About Imunon
This company develops treatments that use DNA to prompt immune responses against cancer and infectious diseases. Its main product candidate is an immunotherapy for advanced ovarian cancer, currently in late-stage testing, and it is also working on a booster shot for COVID-19. The company's platforms are designed to deliver genetic material without using viruses.
Based on the company's 10-K filed Mar 31, 2026.
Nasdaq · Healthcare
Imunon, Inc. (IMNN)
What Is the Price Target for IMNN?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is IMNN a Buy or Sell Right Now?
Thesis
- •Revenue growing 0.0% YoY with UNKNOWN trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for IMNN.
Start Free Trial →Is IMNN Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B
Fair Value
$2.07
7
Moat Score
NONE
4/9
Piotroski Score
-51.1
Altman Z-Score
What Is Smart Money Doing with IMNN?
Insider Signal
NEUTRAL
0 buys / 1 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Braun Donald P | director | Buy | 11,746 | $10K | Nov 6, 2026 |
| Dentzer James E | director | Buy | 13,166 | $11K | Nov 6, 2026 |
| Pellizzari Christine A | director | Buy | 13,166 | $11K | Nov 6, 2026 |
| Fritz Frederick J. | director | Buy | 13 | $11.13 | Nov 6, 2026 |
| Faller Douglas Vincent | officer | Buy | 1,596 | $1K | Nov 6, 2026 |
| Lindborg Stacy | director officer | Buy | 3,804 | $3K | Nov 6, 2026 |
| Tardugno Michael H | director officer | Buy | 9,969 | $8K | Nov 6, 2026 |
| Tardugno Michael H | director officer | Buy | 6,821 | $8K | Oct 23, 2026 |
| Lindborg Stacy | director officer | Buy | 2,603 | $3K | Oct 23, 2026 |
| Faller Douglas Vincent | officer | Buy | 26,741 | $33K | Oct 23, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →IMNN Growth Story
Revenue YoY
0.0%
3yr Revenue CAGR
N/A%
EPS Growth YoY
59.68%
FCF Growth YoY
24.9%
Revenue Trend
UNKNOWN
Dark Pool Trades for IMNN
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for IMNN, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 23:58:08 | $0.64 | 1,956 | $$1K | SELL |
| 22:02:07 | $0.68 | 2,099 | $$1K | SELL |
| 21:44:11 | $0.66 | 6,096 | $$4K | SELL |
| 20:59:33 | $0.64 | 1,000 | $$636 | SELL |
| 20:59:15 | $0.66 | 5,553 | $$4K | SELL |
5 dark pool trades shown · $$11K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Imunon, Inc. (IMNN) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →IMNN — frequently asked questions
What is IMNN stock price today?
Imunon, Inc. (IMNN) is at $0.64, down 11.57% (-$0.08) at the Nov 12, 2026 close.
Why is IMNN stock moving today?
Latest IMNN news — Nov 12, 2026: Imunon holds Q3 2026 earnings call · Nov 12, 2026: Imunon, Inc. filed a report on a major company event (Form 8-K)
What do analysts rate IMNN?
Analyst ratings for IMNN: 1 Buy, 0 Hold, 0 Sell — consensus Buy.
Did IMNN beat earnings?
IMNN last reported on Aug 11, 2026: EPS -$0.54 vs -$0.87 expected — a beat of 37.8%.
Does IMNN pay a dividend?
IMNN does not currently pay a dividend.
What are IMNN support and resistance levels?
Resistance: $0.96, $1.27, $1.47.
What are insiders doing with IMNN?
Insider activity: NEUTRAL, 0 buys and 1 sells in the last 90 days.
What is the latest news on IMNN?
Nov 12, 2026: Imunon holds Q3 2026 earnings call · Nov 12, 2026: Imunon, Inc. filed a report on a major company event (Form 8-K) · Nov 12, 2026: Imunon posts wider quarterly loss than analysts expected